Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Sales (2021 - 2025)

Historic Return on Sales for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to 0.95%.

  • Biofrontera's Return on Sales fell 3200.0% to 0.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.48% for FY2024, which is 1200.0% up from last year.
  • Latest data reveals that Biofrontera reported Return on Sales of 0.95% as of Q3 2025, which was down 3200.0% from 0.59% recorded in Q2 2025.
  • Biofrontera's 5-year Return on Sales high stood at 0.57% for Q1 2022, and its period low was 3.69% during Q3 2021.
  • For the 5-year period, Biofrontera's Return on Sales averaged around 0.75%, with its median value being 0.63% (2021).
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -27800bps in 2021, then soared by 31000bps in 2022.
  • Over the past 5 years, Biofrontera's Return on Sales (Quarter) stood at 1.58% in 2021, then skyrocketed by 83bps to 0.27% in 2022, then skyrocketed by 221bps to 0.33% in 2023, then crashed by -133bps to 0.11% in 2024, then crashed by -756bps to 0.95% in 2025.
  • Its Return on Sales was 0.95% in Q3 2025, compared to 0.59% in Q2 2025 and 0.49% in Q1 2025.